Despite changes, generics continue to face obstacles in Japan

05/21/2013 | BioSpectrum Asia

Although Japan is the world's second-largest pharmaceutical market after the U.S., generics represent only 6.6% of prescription drug sales, largely because of public attitudes skeptical of the effectiveness and safety of unfamiliar brands, especially if the drugs are produced in countries such as India and China. Several factors may help change these views: government efforts to further cut generic-drug prices, higher reimbursements for generics, patent expirations and a rapidly aging population.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ